CELEBREX

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Cyprus, Ecuador, Estonia, France, Germany, Hong Kong SAR China, Ireland, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug CELEBREX contains one active pharmaceutical ingredient (API):

1	Celecoxib UNII JCX84Q7J1L - CELECOXIB
	Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers.
	Read more about Celecoxib

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CELEBREX Capsule	MPI, US: SPL/PLR	FDA, National Drug Code (US)
CELEBREX Capsule, hard	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AH01	Celecoxib	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AH Coxibs
Discover more medicines within M01AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8439E, 8440F
CA	Health Products and Food Branch	02239941, 02239942
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00033152, 00033169, 00566078, 00566084, 00566090, 00566109, 00566138, 00566144, 00566150, 01135251, 01135529, 01713558, 01743832, 03162140, 03162157, 04656134, 04656140, 04656246, 04656252, 04656269, 05458212, 05506454, 05506460, 05506483, 06058880, 06058897, 06058905, 06058911, 06058928, 06058934, 06574848, 06574854, 07544683, 08882382, 08882399, 08882548, 09154302, 09154325, 09154331, 09154348, 10111574, 10111580, 10111597, 10297900, 10297917
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1614-MEE-0116
EE	Ravimiamet	1073641, 1073652, 1073663, 1073674, 1073685, 1073696, 1073708, 1073719, 1073731, 1073742, 1073753, 1073764, 1073775, 1073786, 1073797, 1073809, 1073810, 1842342, 1842353, 1842364, 1852376, 1852387, 1852398
ES	Centro de información online de medicamentos de la AEMPS	034824460, 3400935437068, 63072, 63073
FR	Base de données publique des médicaments	66150367, 68952704
GB	Medicines & Healthcare Products Regulatory Agency	138473, 138475, 144925, 144926, 144929, 161476, 196926, 20087, 20089
HK	Department of Health Drug Office	44730, 44731, 52866
IE	Health Products Regulatory Authority	16863, 16963, 17019, 17030, 17066, 17094, 17304, 17390
IT	Agenzia del Farmaco	034624460
LT	Valstybinė vaistų kontrolės tarnyba	1004062, 1004063, 1010159, 1010160, 1010161, 1010162
MT	Medicines Authority	MA1396/00401, MA1396/00402, PI1438/08501A, PI1438/08502A, PI770/12801A, PI770/12802A, PI908/05303A, PI908/05304A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	031M99
NG	Registered Drug Product Database	04-2108
Switch country to Nigeria in order to find specific presentations of CELEBREX
NL	Z-Index G-Standaard, PRK	58998, 59005
NZ	Medicines and Medical Devices Safety Authority	11684, 20389, 20418, 8515, 8542
PL	Rejestru Produktów Leczniczych	100092708, 100188437
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67264006, W67264007, W67264008, W67265004, W67265006, W67265008
SG	Health Sciences Authority	11240P, 11241P, 13653P
TN	Direction de la Pharmacie et du Médicament	9243101, 9243102, 9243104
TR	İlaç ve Tıbbi Cihaz Kurumu	8699532151384, 8699532151605
US	FDA, National Drug Code	0025-1515, 0025-1520, 0025-1525, 0025-1530, 55289-451, 55289-475, 61919-046, 63187-079, 63629-3021, 80425-0037, 80425-0039, 80425-0040
ZA	Health Products Regulatory Authority	33/3.1/0332, 33/3.1/0333